PL

Philomena Lip

Associate at Advent Life Sciences

United Kingdom

Overview 

Philomena Lip is a Venture Capitalist at Advent Life Sciences in the UK, specializing in investing in Series A and Seed stage companies in the BioTech sector in London. She has a background in strategy consulting at McKinsey and has been recognized as a Next Generation Women Leader, showcasing her leadership and analytical skills.

Work Experience 

  • Associate

    2023 - Current

  • Analyst

    2021 - 2022

  • Operations Strategy Lead

    2019 - 2021

  • M&A

    2017 - 2019

    Deals announced: - £4.7bn sale of RPC Group plc to Berry Global - £250m carveout and sale of Link’s Corporate and Private Client Services business to Apex - Restructuring of Interserve - Sale of Ammeraal Beltech to Partners Group I was involved in the formation of the first Balance & Inclusion committee, a committee that represented all factions of the bank (division, seniority, gender, ethnicity, disability, carers) to address any issues that they may face.

  • Research student

    2016 - 2017

    Worked as a student in the lab of Prof. Sir Peter Ratcliffe (Nobel Prize Winner, 2019), examining the effects of different HIF isoforms and hypoxia on proliferation of the carotid body and adrenal medulla.

  • Student Writer

    2015 - 2016

    Published articles on student life (see below for titles).

The Telegraph is a publishing company offering local news and information.

  • Research student

    2015 - 2015

    Interned in a biochemistry lab under Dr. Marilene Demasi which involved conducting pharmacokinetic experiments with the proteasome in mice and yeast cells. Techniques used: dissection, western blotting, cell growth, fluorescence assays. Also attended the International Union for Biochemistry and Molecular Biology Conference in Foz do Iguacu, Brazil.

Articles About Philomena

Relevant Websites